Introduction - Swiss HIV Cohort Study

news and press releases

21^st Sep 2022	Patel et al., Dolutegravir in pregnancy for HIV
15^th Sep 2022	Kusejko et al., COVERALL to study Covid-19 vaccine response
1^st Sep 2022	Thoueille et al., Long-acting cabotegravir and rilpivirine
18^th Aug 2022	Chammartin et al., Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in PWH

previous newslettersubscribe to newsletter

information for

SHCS participants and community

agenda

next meetings

SB	09^th November 2022
CLC	09^th November 2022
MoCHiV	19^th October 2022
YRG	09^th November 2022
FA	16^th June 2022

documents

publications

publications

The Swiss HIV Cohort Study (SHCS), established in 1988, is a systematic longitudinal study enrolling HIV-infected individuals in Switzerland. It is a collaboration of all Swiss University Hospital infectious disease outpatient clinics, two large cantonal hospitals, all with affiliated laboratories, and with affiliated smaller hospitals and private physicians caring for HIV patients.

The major goal is to provide optimal patient care, reduce HIV transmission and to conduct research.

The Swiss Mother and Child HIV Cohort Study (MoCHiV) is integrated into the SHCS. It aims at preventing mother-to-child transmission and enrolls HIV-infected pregnant women and their children.